Edition:
United States

Protalex Inc (PRTX.PK)

PRTX.PK on OTC Markets Group

0.64USD
26 Jul 2017
Change (% chg)

-- (--)
Prev Close
$0.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,890
52-wk High
$3.00
52-wk Low
$0.50

PRTX.PK

Chart for PRTX.PK

About

Protalex, Inc. is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company's lead product candidate, PRTX-100, is a formulation of the Staphylococc... (more)
No analyst recommendations are available for PRTX.PK.

Overall

Beta: 1.16
Market Cap(Mil.): $18.30
Shares Outstanding(Mil.): 28.77
Dividend: --
Yield (%): --

Financials

  PRTX.PK Industry Sector
P/E (TTM): -- 11.67 15.75
EPS (TTM): -0.18 -- --
ROI: -26,845.29 -10.11 -8.37
ROE: -- -9.91 -7.95

Earnings vs. Estimates

No consensus analysis data available.